Cevher Ozcan to Anti-Arrhythmia Agents
This is a "connection" page, showing publications Cevher Ozcan has written about Anti-Arrhythmia Agents.
Connection Strength
1.044
-
Activation of AMP-Activated Protein Kinases Prevents Atrial Fibrillation. J Cardiovasc Transl Res. 2021 06; 14(3):492-502.
Score: 0.739
-
Severe Torsades de Pointes with acquired QT prolongation. Eur Heart J Acute Cardiovasc Care. 2019 Dec; 8(8):775-776.
Score: 0.137
-
Effective pharmacotherapy against oxidative injury: alternative utility of an ATP-sensitive potassium channel opener. J Cardiovasc Pharmacol. 2007 Oct; 50(4):411-8.
Score: 0.076
-
Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol. 2002 Feb; 282(2):H531-9.
Score: 0.051
-
Impact of Atrial Fibrillation Ablation on Recurrent Hospitalization: A Nationwide Cohort Study. JACC Clin Electrophysiol. 2019 03; 5(3):330-339.
Score: 0.041